Altamira Therapeutics Ltd. Retained Earnings
Altamira Therapeutics Ltd. (CYTOF) had Retained Earnings of -$4.04 million as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:RetainedEarnings · last filed 2025-08-29
- 2023-12-31: Retained Earnings -18.05M CHF.
- 2023-06-30: Retained Earnings -19.85M CHF.
- 2022-12-31: Retained Earnings -201.43M CHF.
- 2022-06-30: Retained Earnings -183.54M CHF; Retained Earnings as first filed -182.60M CHF.
CHF
| Period end | Retained Earnings | Retained Earnings as first filed |
|---|---|---|
| 2023-12-31 | -18.05M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | -19.85M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | -201.43M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | -183.54M CHF 6-K/A · filed 2023-08-21 | -182.60M CHF 6-K · filed 2022-11-30 |
| 2021-12-31 | -175.69M CHF 6-K/A · filed 2023-08-21 | -176.02M CHF 20-F · filed 2022-04-12 |
| 2021-06-30 | -164.91M CHF 6-K · filed 2021-09-08 | |
| 2020-12-31 | -160.64M CHF 20-F · filed 2022-04-12 | |
| 2020-06-30 | -155.35M CHF 6-K/A · filed 2020-09-17 | |
| 2019-12-31 | -152.78M CHF 20-F · filed 2021-03-31 | |
| 2019-06-30 | -149.71M CHF 6-K · filed 2019-08-15 | |
| 2018-12-31 | -146.30M CHF 20-F · filed 2020-04-16 | |
| 2017-12-31 | -136.13M CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | -112.34M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Retained Earnings |
|---|---|
| 2025-06-30 | -$4.04M 6-K · filed 2025-08-29 |
| 2024-12-31 | -$3.03M 6-K · filed 2025-08-29 |
| 2024-06-30 | $1.26M 6-K · filed 2024-09-24 |
| 2023-12-31 | -$21.35M 20-F · filed 2025-04-30 |
| 2023-01-01 | -$226.26M 20-F · filed 2025-04-30 |